• Wordpackage: WP1 : Targeting residual disease: a path to cure?
  • Institution: Centre Léon Bérard, Lille
  • Current position:
    • Department of Medicine, Centre Léon Bérard, Lyon, France. Cancer Research center of Lyon, Department of tumor evasion, Resistance and Immunity, Team “Integrated analysis of cancer dynamics” (Dr Saintigny), UMR INSERM 1052/ CNRS 5286 Mixte CLB

Aurelie Swalduz practices in Lyon. Her top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Small Cell Lung Cancer (SCLC). Her clinical research consists of co-authoring 35 peer reviewed articles and participating in 7 clinical trials in the past 15 years.

Cookies user preferences
We use cookies to ensure you to get the best experience on our website. If you decline the use of cookies, this website may not function as expected.
Accept all
Decline all
Analytics
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.
Google Analytics
Accept
Decline
Advertisement
If you accept, the ads on the page will be adapted to your preferences.
Google Ad
Accept
Decline
Save